Kezar Life Sciences CEO John Fowler's 2018 pay jumps 125% to $1.8M
Kezar Life Sciences reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
Kezar Life Sciences reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, three executives at Kezar Life Sciences received on average a compensation package of $1.3M, a 71% increase compared to previous year.
Average pay of disclosed executives at Kezar Life Sciences
John Fowler, Chief Executive Officer, received $1.8M in total, which increased by 125% compared to 2017. 60% of Fowler's compensation, or $1.1M, was in option awards. Fowler also received $248K in non-equity incentive plan, $460K in salary, as well as $12K in other compensation.
Niti Goel, Chief Medical Officer, received a compensation package of $1.2M. 68% of the compensation package, or $822K, was in option awards.
Christopher Kirk, Chief Scientific Officer, earned $962K in 2018, a 29% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 30, 2019.